Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

Vaccines in the era of genomics: the pneumococcal challenge.

Barocchi MA, Censini S, Rappuoli R.

Vaccine. 2007 Apr 20;25(16):2963-73. Epub 2007 Jan 30. Review.

PMID:
17324490
[PubMed - indexed for MEDLINE]
2.

Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.

Meng C, Lin H, Huang J, Wang H, Cai Q, Fang L, Guo Y.

Microb Pathog. 2009 Sep;47(3):151-6. doi: 10.1016/j.micpath.2009.05.004. Epub 2009 May 23.

PMID:
19467319
[PubMed - indexed for MEDLINE]
3.

Analysis of structure and function of putative surface-exposed proteins encoded in the Streptococcus pneumoniae genome: a bioinformatics-based approach to vaccine and drug design.

Rigden DJ, Galperin MY, Jedrzejas MJ.

Crit Rev Biochem Mol Biol. 2003;38(2):143-68. Review.

PMID:
12749697
[PubMed - indexed for MEDLINE]
4.

Advances in pneumococcal vaccines: what are the advantages for the elderly?

Vila-Córcoles A.

Drugs Aging. 2007;24(10):791-800. Review.

PMID:
17896829
[PubMed - indexed for MEDLINE]
5.

Developing antibacterial vaccines in genomics and proteomics era.

Kaushik DK, Sehgal D.

Scand J Immunol. 2008 Jun;67(6):544-52. doi: 10.1111/j.1365-3083.2008.02107.x. Epub 2008 Apr 4. Review.

PMID:
18397199
[PubMed - indexed for MEDLINE]
6.

Confronting the pneumococcus: a target shift or bullet change?

Obaro SK.

Vaccine. 2000 Dec 8;19(9-10):1211-7. Review.

PMID:
11137259
[PubMed - indexed for MEDLINE]
7.

Genome-based approaches to develop vaccines against bacterial pathogens.

Serruto D, Serino L, Masignani V, Pizza M.

Vaccine. 2009 May 26;27(25-26):3245-50. doi: 10.1016/j.vaccine.2009.01.072. Epub 2009 Feb 5. Review.

PMID:
19200820
[PubMed - indexed for MEDLINE]
8.

Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies.

Tai SS.

Crit Rev Microbiol. 2006;32(3):139-53. Review.

PMID:
16893751
[PubMed - indexed for MEDLINE]
9.

Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era.

Dinleyici EC, Yargic ZA.

Expert Rev Vaccines. 2008 Nov;7(9):1367-94. doi: 10.1586/14760584.7.9.1367. Review.

PMID:
18980540
[PubMed - indexed for MEDLINE]
10.

Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.

Pletz MW, Maus U, Krug N, Welte T, Lode H.

Int J Antimicrob Agents. 2008 Sep;32(3):199-206. doi: 10.1016/j.ijantimicag.2008.01.021. Epub 2008 Apr 18. Review.

PMID:
18378430
[PubMed - indexed for MEDLINE]
11.

Pneumococcal conjugate vaccines. A review.

Galiza EP, Heath PT.

Minerva Med. 2007 Apr;98(2):131-43. Review.

PMID:
17519855
[PubMed - indexed for MEDLINE]
12.

Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge.

Campos IB, Darrieux M, Ferreira DM, Miyaji EN, Silva DA, Arêas AP, Aires KA, Leite LC, Ho PL, Oliveira ML.

Microbes Infect. 2008 Apr;10(5):481-8. doi: 10.1016/j.micinf.2008.01.007. Epub 2008 Jan 20.

PMID:
18403234
[PubMed - indexed for MEDLINE]
13.

Understanding the link between pneumococcal serotypes and invasive disease.

Soley C, Arguedas A.

Vaccine. 2009 Aug 21;27 Suppl 3:C19-21. doi: 10.1016/j.vaccine.2009.06.003. Epub 2009 Jun 16.

PMID:
19535183
[PubMed - indexed for MEDLINE]
14.

Identification of potential vaccine candidates against Streptococcus pneumoniae by reverse vaccinology approach.

Talukdar S, Zutshi S, Prashanth KS, Saikia KK, Kumar P.

Appl Biochem Biotechnol. 2014 Mar;172(6):3026-41. doi: 10.1007/s12010-014-0749-x. Epub 2014 Jan 31.

PMID:
24482282
[PubMed - indexed for MEDLINE]
15.

The role of Pneumococcal vaccine.

Braido F, Bellotti M, De Maria A, Cazzola M, Canonica GW.

Pulm Pharmacol Ther. 2008 Aug;21(4):608-15. doi: 10.1016/j.pupt.2008.04.001. Epub 2008 Apr 25. Review.

PMID:
18502670
[PubMed - indexed for MEDLINE]
16.

Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.

Smith CM, Lo Passo C, Scuderi A, Kolberg J, Baxendale H, Goldblatt D, Oggioni MR, Felici F, Andrew PW.

Eur J Immunol. 2009 Jun;39(6):1527-35. doi: 10.1002/eji.200839091.

PMID:
19499518
[PubMed - indexed for MEDLINE]
17.

The use of genomics in microbial vaccine development.

Bambini S, Rappuoli R.

Drug Discov Today. 2009 Mar;14(5-6):252-60. doi: 10.1016/j.drudis.2008.12.007. Epub 2009 Jan 15. Review.

PMID:
19150507
[PubMed - indexed for MEDLINE]
18.

Combat pneumococcal infections: adhesins as candidates for protein-based vaccine development.

Gamez G, Hammerschmidt S.

Curr Drug Targets. 2012 Mar;13(3):323-37. Review.

PMID:
22206255
[PubMed - indexed for MEDLINE]
19.

Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae.

Shah P, Briles DE, King J, Hale Y, Swiatlo E.

Exp Biol Med (Maywood). 2009 Apr;234(4):403-9. doi: 10.3181/0809-RM-269. Epub 2009 Jan 28.

PMID:
19176871
[PubMed - indexed for MEDLINE]
20.

Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV).

Croxtall JD, Keating GM.

Paediatr Drugs. 2009;11(5):349-57. doi: 10.2165/11202760-000000000-00000. Review.

PMID:
19725600
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk